Ulrika Segersten

3.0k total citations
37 papers, 1.3k citations indexed

About

Ulrika Segersten is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Ulrika Segersten has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 13 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Ulrika Segersten's work include Bladder and Urothelial Cancer Treatments (23 papers), Urinary and Genital Oncology Studies (10 papers) and Vitamin D Research Studies (7 papers). Ulrika Segersten is often cited by papers focused on Bladder and Urothelial Cancer Treatments (23 papers), Urinary and Genital Oncology Studies (10 papers) and Vitamin D Research Studies (7 papers). Ulrika Segersten collaborates with scholars based in Sweden, Denmark and Spain. Ulrika Segersten's co-authors include Per‐Uno Malmström, Per Hellman, Gunnar Westin, Göran Åkerström, Pamela Correa, Lars Dyrskjøt, Torben F. Ørntoft, Sara Bergström Lind, Kenneth Wester and Henning Dralle and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ulrika Segersten

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrika Segersten Sweden	20	538	474	288	235	228	37	1.3k
Carol Wong Hong Kong	14	494 0.9×	253 0.5×	75 0.3×	177 0.8×	210 0.9×	31	1.2k
Woon Yong Jung South Korea	18	339 0.6×	145 0.3×	70 0.2×	152 0.6×	203 0.9×	41	783
Masachika Tani Japan	22	1.3k 2.4×	178 0.4×	336 1.2×	216 0.9×	458 2.0×	35	1.9k
William G. Dilley United States	21	461 0.9×	544 1.1×	186 0.6×	130 0.6×	636 2.8×	40	2.1k
J Hanai Japan	9	535 1.0×	62 0.1×	102 0.4×	67 0.3×	219 1.0×	19	816
Vivian Grill Australia	22	566 1.1×	95 0.2×	109 0.4×	212 0.9×	989 4.3×	43	1.5k
Norihito Soga Japan	16	611 1.1×	214 0.5×	24 0.1×	460 2.0×	277 1.2×	68	1.2k
Ingrid Raab Austria	10	391 0.7×	297 0.6×	117 0.4×	288 1.2×	685 3.0×	10	1.2k
Elise Nilsson Sweden	15	657 1.2×	112 0.2×	34 0.1×	192 0.8×	213 0.9×	19	988
Iwao Nakayama Japan	19	239 0.4×	420 0.9×	205 0.7×	169 0.7×	282 1.2×	92	1.2k

Countries citing papers authored by Ulrika Segersten

Since Specialization

Citations

This map shows the geographic impact of Ulrika Segersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Segersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Segersten more than expected).

Fields of papers citing papers by Ulrika Segersten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika Segersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Segersten. The network helps show where Ulrika Segersten may publish in the future.

Co-authorship network of co-authors of Ulrika Segersten

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika Segersten. A scholar is included among the top collaborators of Ulrika Segersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika Segersten. Ulrika Segersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Türker, Polat, Per‐Uno Malmström, Artur Mezheyeuski, et al.. (2023). Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer. BMC Cancer. 23(1). 605–605. 7 indexed citations

Furuya, Hideki, Yuka Sasaki, Runpu Chen, et al.. (2022). PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity. Scientific Reports. 12(1). 12186–12186. 12 indexed citations

Türker, Polat, et al.. (2021). Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer. Translational research. 235. 77–84. 3 indexed citations

Mezheyeuski, Artur, Ulrika Segersten, Lina Leiss, et al.. (2020). Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome. Scientific Reports. 10(1). 281–281. 44 indexed citations

Malmström, Per‐Uno, et al.. (2017). Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non–muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 35(8). 532.e1–532.e6. 20 indexed citations

Edgren, Gustaf, et al.. (2015). Courses for tutors in problem-based learning. Current challenges at four Swedish universities. 5(1). 47–64. 3 indexed citations

Lind, Sara Bergström, E. Sjöstedt, Teresita Díaz de Ståhl, et al.. (2014). The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer. British Journal of Cancer. 111(6). 1180–1187. 32 indexed citations

Segersten, Ulrika, Yael Spector, Yaron Goren, Sarit Tabak, & Per‐Uno Malmström. (2014). The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(5). 613–618. 16 indexed citations

Andersson, G., Alexander Gaber, Björn Nodin, et al.. (2014). Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts. BMC Urology. 14(1). 36–36. 17 indexed citations

10.

Segersten, Ulrika, Eugenia Kuteeva, Henrik Johannesson, et al.. (2013). Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer. British Journal of Cancer. 108(11). 2321–2328. 45 indexed citations

11.

Fristrup, Niels, Karin Birkenkamp‐Demtröder, Thomas Reinert, et al.. (2012). Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer. American Journal Of Pathology. 182(2). 339–349. 67 indexed citations

12.

Dyrskjøt, Lars, Thomas Reinert, Alexey Novoradovsky, et al.. (2012). Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR. British Journal of Cancer. 107(8). 1392–1398. 27 indexed citations

13.

Fristrup, Niels, Benedicte Parm Ulhøi, Karin Birkenkamp‐Demtröder, et al.. (2012). Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer. American Journal Of Pathology. 180(5). 1824–1834. 69 indexed citations

14.

Lind, Sara Bergström, Corina Mayrhofer, Ulrika Segersten, et al.. (2011). Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. PROTEOMICS. 12(1). 135–144. 81 indexed citations

15.

Nord, Helena, Ulrika Segersten, Johanna Sandgren, et al.. (2009). Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma. International Journal of Cancer. 126(6). 1390–1402. 55 indexed citations

16.

Botling, Johan, Karolina Edlund, Ulrika Segersten, et al.. (2009). Impact of Thawing on RNA Integrity and Gene Expression Analysis in Fresh Frozen Tissue. Diagnostic Molecular Pathology. 18(1). 44–52. 81 indexed citations

17.

Segersten, Ulrika, Pernille Holm, Lise Binderup, et al.. (2004). Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells. The Journal of Steroid Biochemistry and Molecular Biology. 88(3). 289–294. 4 indexed citations

18.

Correa, Pamela, Ulrika Segersten, Per Hellman, Göran Åkerström, & Gunnar Westin. (2002). Increased 25-Hydroxyvitamin D₃1α-Hydroxylase and Reduced 25-Hydroxyvitamin D₃24-Hydroxylase Expression in Parathyroid Tumors: New Prospects for Treatment of Hyperparathyroidism with Vitamin D. The Journal of Clinical Endocrinology & Metabolism. 87(12). 5826–5829. 40 indexed citations

19.

Segersten, Ulrika, Pamela Correa, Martin Hewison, et al.. (2002). 25-Hydroxyvitamin D₃-1α-Hydroxylase Expression in Normal and Pathological Parathyroid Glands. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2967–2972. 137 indexed citations

20.

Segersten, Ulrika. (2002). 25-Hydroxyvitamin D3-1 -Hydroxylase Expression in Normal and Pathological Parathyroid Glands. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2967–2972. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact